SCHEMBL16981796

SCHEMBL16981796

C=Cc1cccc(Cl)c1C(=O)C(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.46
▸ POLB P06746 1/20 0.42
▸ HPGD P15428 2/20 0.41
▸ GSR P00390 1/20 0.39
▸ NPC1 O15118 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ RORC P51449 1/20 0.36
▸ ITGB1 P05556 2/20 0.35
▸ ITGA4 P13612 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ FEN1 P39748 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13028740 0.82 ALDH1A1 (0.54) ALDH1A1POLBHPGDNPC1GLA
SCHEMBL16984688 0.81 ALDH1A1 (0.50) ALDH1A1HPGDGSRNPC1GLA
SCHEMBL8937915 0.79 ALDH1A1 (0.52) ALDH1A1HPGDGSRNPC1GLA
SCHEMBL20275217 0.78 ALDH1A1 (0.50) ALDH1A1HPGDGSRSMN1; SMN2MAPT
SCHEMBL15570103 0.77 CA12 (0.47) ALDH1A1POLBHPGDGSRNPC1
SCHEMBL13727019 0.75 TYK2 (0.47) ALDH1A1POLBITGB1ITGA4GAA
SCHEMBL13543212 0.74 GAA (0.54) ALDH1A1POLBGAAMAPTRAB9A
SCHEMBL16981797 0.73 POLB (0.42) ALDH1A1POLBHPGDHTTRORC
SCHEMBL18671762 0.71 TYK2 (0.51) ALDH1A1POLBSMN1; SMN2RORCITGB1
Acetic Acid SCHEMBL27301119 0.69 ALDH1A1 (0.72) ALDH1A1HPGDGSRNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10196354-B2 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof MERCK SHARP & DOHME CORP. (US) 2019-02-05 — — US disclosed
US-20180022701-A1 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF MERCK SHARP & DOHME LLC 2018-01-25 — — US disclosed
US-20180022701-A1 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF MERCK SHARP & DOHME LLC 2018-01-25 — — US disclosed
US-9745265-B2 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof MERCK SHARP & DOHME CORP. (US) 2017-08-29 — — US disclosed
US-9745265-B2 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof MERCK SHARP & DOHME CORP. (US) 2017-08-29 — — US disclosed
US-20150218096-A1 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF MERCK SHARP & DOHME LLC 2015-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10196354-B2 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof RORB, RORA, RORC ALDH1A1 263/4885POLB 2997/4885HPGD 1172/4885
US-20180022701-A1 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF RORB, RORA, RORC ALDH1A1 263/4885POLB 2997/4885HPGD 1172/4885
US-20150218096-A1 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF RORB, RORA, RORC ALDH1A1 263/4885POLB 2997/4885HPGD 1172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback